217 related articles for article (PubMed ID: 11165993)
21. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE
Cochrane Database Syst Rev; 2004; (2):CD004062. PubMed ID: 15106235
[TBL] [Abstract][Full Text] [Related]
22. Impact of Helicobacter pylori Eradication on Incidence of Peptic Ulcer Bleeding in Patients Taking Regular Aspirin.
Yadlapati R
Gastroenterology; 2023 May; 164(6):1017. PubMed ID: 36502864
[No Abstract] [Full Text] [Related]
23. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection.
Ramsoekh D; van Leerdam ME; Rauws EA; Tytgat GN
Clin Gastroenterol Hepatol; 2005 Sep; 3(9):859-64. PubMed ID: 16234022
[TBL] [Abstract][Full Text] [Related]
24. Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis.
El-Serag HB; Graham DY; Richardson P; Inadomi JM
Arch Intern Med; 2002 Oct; 162(18):2105-10. PubMed ID: 12374519
[TBL] [Abstract][Full Text] [Related]
25. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
[TBL] [Abstract][Full Text] [Related]
26. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
[TBL] [Abstract][Full Text] [Related]
27. Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users.
Chan FK; Ching JY; Suen BY; Tse YK; Wu JC; Sung JJ
Gastroenterology; 2013 Mar; 144(3):528-35. PubMed ID: 23333655
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
[TBL] [Abstract][Full Text] [Related]
29. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Taha AS; McCloskey C; McSkimming P; McConnachie A
Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):469-476. PubMed ID: 29754836
[TBL] [Abstract][Full Text] [Related]
30. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
[TBL] [Abstract][Full Text] [Related]
31. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
Lai KC; Lam SK; Chu KM; Wong BC; Hui WM; Hu WH; Lau GK; Wong WM; Yuen MF; Chan AO; Lai CL; Wong J
N Engl J Med; 2002 Jun; 346(26):2033-8. PubMed ID: 12087138
[TBL] [Abstract][Full Text] [Related]
32. Optimal management of peptic ulcer disease in the elderly.
Pilotto A; Franceschi M; Maggi S; Addante F; Sancarlo D
Drugs Aging; 2010 Jul; 27(7):545-58. PubMed ID: 20583849
[TBL] [Abstract][Full Text] [Related]
33. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.
Stack WA; Atherton JC; Hawkey GM; Logan RF; Hawkey CJ
Aliment Pharmacol Ther; 2002 Mar; 16(3):497-506. PubMed ID: 11876703
[TBL] [Abstract][Full Text] [Related]
34. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
Ji KY; Hu FL
World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960
[TBL] [Abstract][Full Text] [Related]
35. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
[No Abstract] [Full Text] [Related]
36. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs.
Hawkey CJ
Gut; 2000 Mar; 46(3):310-1. PubMed ID: 10673289
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal injury from NSAID therapy. How to reduce the risk of complications.
Lanas A
Postgrad Med; 2005 Jun; 117(6):23-8, 31. PubMed ID: 16001765
[TBL] [Abstract][Full Text] [Related]
38. Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users.
Papatheodoridis GV; Archimandritis AJ
World J Gastroenterol; 2005 Jul; 11(25):3811-6. PubMed ID: 15991274
[TBL] [Abstract][Full Text] [Related]
39. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs.
Cullen DJ; Hawkey GM; Greenwood DC; Humphreys H; Shepherd V; Logan RF; Hawkey CJ
Gut; 1997 Oct; 41(4):459-62. PubMed ID: 9391242
[TBL] [Abstract][Full Text] [Related]
40. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs.
Nakashima S; Arai S; Mizuno Y; Yoshino K; Ando S; Nakamura Y; Sugawara K; Koike M; Saito E; Naito M; Nakao M; Ito H; Hamaoka K; Rai F; Asakura Y; Akamatu M; Fujimori K; Inao M; Imai Y; Ota S; Fujiwara K; Shiibashi M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():60-6. PubMed ID: 15943849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
